← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2009Last known activity
Jul 7, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT03968224Lead sponsorPhase 2/Phase 3Jul 7, 2018
- NCT03968224Reponsible party - principal investigatorPhase 2/Phase 3Jul 7, 2018
- NCT01072799Overall official - principal investigatorPhase 2Oct 1, 2009
Details
- Last known activity
- Jul 7, 2018